P506: ACHIEVEMENT OF MEASURABLE RESIDUAL DISEASE CLEARANCE IS A STRONGER PREDICTOR OF PATIENT OUTCOME THAN TREATMENT INTENSITY IN NEWLY DIAGNOSED PATIENTS WITH ACUTE MYELOID LEUKEMIA - A. Bazinet; T. Kadia; N. Short; G. Borthakur; S. Wang; S. Loghavi; J. Jorgensen; K. Patel; C. DiNardo; N. Daver; Y. Alvarado; F. Haddad; et al. (HemaSphere, 2022)